PLEUROPULMONARY INVOLVEMENT DURING BROMOCRIPTINE TREATMENT

被引：26

作者：

KINNUNEN, E ^{[1
]}

VILJANEN, A ^{[1
]}

机构：

[1] MELTOLA HOSP,DEPT PULM MED,HELSINKI,FINLAND

来源：

CHEST | 1988年 / 94卷 / 05期

关键词：

D O I：

10.1378/chest.94.5.1034

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：1034 / 1036

页数：3

共 12 条

[1] BROMOCRIPTINE IN PARKINSONISM [J].

CALNE, DB ;

TEYCHENNE, PF ;

CLAVERIA, LE ;

EASTMAN, R ;

GREENACRE, JK ;

PETRIE, A .

BMJ-BRITISH MEDICAL JOURNAL, 1974, 4 (5942) :442-444

[2] EFFECT OF ERGOT DRUGS ON CENTRAL CATECHOLAMINE NEURONS - EVIDENCE FOR A STIMULATION OF CENTRAL DOPAMINE NEURONS [J].

CORRODI, H ;

FUXE, K ;

HOKFELT, T ;

LIDBRINK, P ;

UNGERSTEDT, U .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (05) :409-412

[3] PLEURAL EFFUSION AND FIBROSIS DURING TREATMENT WITH METHYSERGIDE [J].

HINDLE, W ;

POSNER, E ;

SWEETNAM, MT ;

TAN, RSH .

BRITISH MEDICAL JOURNAL, 1970, 1 (5696) :605-&

[4] RECENT ADVANCES IN THE TREATMENT OF PARKINSONS-DISEASE - THE ROLE OF BROMOCRIPTINE [J].

LEWITT, PA ;

CALNE, DB .

JOURNAL OF NEURAL TRANSMISSION, 1981, 51 (1-2) :175-184

[5] LYMPHOCYTE-T AND LYMPHOCYTE-B IN PLEURAL EFFUSIONS [J].

PETTERSSON, T ;

KLOCKARS, M ;

HELLSTROM, PE ;

RISKA, H ;

WANGEL, A .

CHEST, 1978, 73 (01) :49-51

[6] COMBINED BROMOCRIPTINE-LEVODOPA THERAPY EARLY IN PARKINSONS-DISEASE [J].

RINNE, UK .

NEUROLOGY, 1985, 35 (08) :1196-1198

[7]

RINNE UK, 1981, LANCET, V1, P44

[8]

SAHN SA, 1985, CLIN CHEST MED, V6, P83

[9]

TORNLING G, 1986, EUR J RESPIR DIS, V68, P35

[10]

VERGERET J, 1984, SEM HOP PARIS, V60, P741

← 1 2 →